LLY

Eli Lilly and Company · GETTEX:LLY

1,269.00 EUR33.40 +2.70%

Eli Lilly and Company (GETTEX:LLY) last traded at 1,269.00 EUR, up 2.70% on the day. Over the past year the stock is up 81.91%. Its 52-week range is 727.20 to 1,294.60. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open1,240.00

Day range1,238.60 – 1,294.60

52-week range727.20 – 1,294.60

Volume717

Average volume (10 days)464

Market cap (USD)1.33 T

P/E47.23

EPS (TTM) (USD)30.44

Dividend yield0.47%

Beta (1 year)0.3795

Revenue (TTM) (USD)86.46 B

Employees50.00 K

Performance

+9.40%1 week

+21.41%1 month

+26.22%3 months

+72.82%6 months

+37.55%Year to date

+81.91%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

1,306.65 EUR

The average 1-year price target, +2.97% from the last price. See the forecast

Latest headlines

Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.